| The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: data from the multinational sampling antibiotics in renal … JA Roberts, GM Joynt, A Lee, G Choi, R Bellomo, S Kanji, MY Mudaliar, ... Clinical Infectious Diseases 72 (8), 1369-1378, 2021 | 103 | 2021 |
| Population pharmacokinetics of fosfomycin in critically ill patients SL Parker, F Frantzeskaki, SC Wallis, C Diakaki, H Giamarellou, ... Antimicrobial agents and chemotherapy 59 (10), 6471-6476, 2015 | 82 | 2015 |
| What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review S Parker, J Lipman, D Koulenti, G Dimopoulos, JA Roberts International journal of antimicrobial agents 42 (4), 289-293, 2013 | 76 | 2013 |
| Optimizing dosing of antibiotics in critically ill patients SL Parker, FB Sime, JA Roberts Current Opinion in Infectious Diseases 28 (6), 497-504, 2015 | 57 | 2015 |
| Quantitative bioanalytical validation of fosfomycin in human whole blood with volumetric absorptive microsampling SL Parker, JA Roberts, J Lipman, SC Wallis Bioanalysis 7 (19), 2585-2595, 2015 | 52 | 2015 |
| Population pharmacokinetics of unbound ceftolozane and tazobactam in critically ill patients without renal dysfunction FB Sime, M Lassig-Smith, T Starr, J Stuart, S Pandey, SL Parker, ... Antimicrobial Agents and Chemotherapy 63 (10), 10.1128/aac. 01265-19, 2019 | 40 | 2019 |
| Clinical application of microsampling versus conventional sampling techniques in the quantitative bioanalysis of antibiotics: a systematic review YC Guerra Valero, SC Wallis, J Lipman, C Stove, JA Roberts, SL Parker Bioanalysis 10 (6), 407-423, 2018 | 40 | 2018 |
| Uncertainty in antibiotic dosing in critically ill neonate and pediatric patients: can microsampling provide the answers? T Dorofaeff, RM Bandini, J Lipman, DE Ballot, JA Roberts, SL Parker Clinical therapeutics 38 (9), 1961-1975, 2016 | 39 | 2016 |
| The use and risks of antibiotics in critically ill patients KJ Denny, MO Cotta, SL Parker, JA Roberts, J Lipman Expert opinion on drug safety 15 (5), 667-678, 2016 | 38 | 2016 |
| A simple LC–MS/MS method using HILIC chromatography for the determination of fosfomycin in plasma and urine: Application to a pilot pharmacokinetic study in humans SL Parker, J Lipman, JA Roberts, SC Wallis Journal of Pharmaceutical and Biomedical Analysis 105, 39-45, 2015 | 36 | 2015 |
| Effect of time on recovery of plasma microsamples for the quantitative determination of vancomycin SL Parker, YC Guerra Valero, J Lipman, JA Roberts, SC Wallis Bioanalysis 8 (21), 2235-2242, 2016 | 32 | 2016 |
| A validated method for the quantification of fosfomycin on dried plasma spots by HPLC–MS/MS: Application to a pilot pharmacokinetic study in humans SL Parker, J Lipman, G Dimopoulos, JA Roberts, SC Wallis Journal of Pharmaceutical and Biomedical Analysis 115, 509-514, 2015 | 32 | 2015 |
| A UHPLC–MS/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluent S Naicker, YCG Valero, JLO Meija, J Lipman, JA Roberts, SC Wallis, ... Journal of Pharmaceutical and Biomedical Analysis 148, 324-333, 2018 | 30 | 2018 |
| Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients FB Sime, CJ Byrne, S Parker, J Stuart, J Butler, T Starr, S Pandey, ... Critical Care 23, 1-12, 2019 | 28 | 2019 |
| Ex Vivo Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam FB Sime, S Pandey, N Karamujic, S Parker, E Alexander, J Loutit, S Durso, ... Antimicrobial Agents and Chemotherapy 62 (10), 10.1128/aac. 01306-18, 2018 | 28 | 2018 |
| A population pharmacokinetic model-guided evaluation of ceftolozane-tazobactam dosing in critically ill patients undergoing continuous venovenous hemodiafiltration FB Sime, M Lassig-Smith, T Starr, J Stuart, S Pandey, SL Parker, ... Antimicrobial Agents and Chemotherapy 64 (1), 10.1128/aac. 01655-19, 2019 | 26 | 2019 |
| Determination of cefalothin and cefazolin in human plasma, urine and peritoneal dialysate by UHPLC‐MS/MS: Application to a pilot pharmacokinetic study in humans SL Parker, YC Guerra Valero, DM Roberts, J Lipman, JA Roberts, ... Biomedical Chromatography 30 (6), 872-879, 2016 | 25 | 2016 |
| Is there a role for microsampling in antibiotic pharmacokinetic studies? SL Parker, T Dorofaeff, J Lipman, DE Ballot, RM Bandini, SC Wallis, ... Expert opinion on drug metabolism & toxicology 12 (6), 601-614, 2016 | 24 | 2016 |
| An LC–MS/MS method to determine vancomycin in plasma (total and unbound), urine and renal replacement therapy effluent SL Parker, YC Guerra Valero, JL Ordóñez Mejia, C Roger, J Lipman, ... Bioanalysis 9 (12), 911-924, 2017 | 21 | 2017 |
| Intravenous fosfomycin for the treatment of multidrug-resistant pathogens: what is the evidence on dosing regimens? G Dimopoulos, D Koulenti, SL Parker, JA Roberts, K Arvaniti, G Poulakou Expert Review of Anti-infective Therapy 17 (3), 201-210, 2019 | 20 | 2019 |
